Key result
Lower systolic blood pressure targets (<130 mm Hg) reduced composite major cardiovascular events by 24% and all-cause mortality by 13% in cited meta-analyses.
Why the study?
Does targeting a lower systolic blood pressure (< 130 mm Hg) reduce cardiovascular events and cognitive dysfunction compared to a conservative target (< 140 mm Hg) in adults with hypertension?
Does targeting a lower systolic blood pressure (< 130 mm Hg) reduce cardiovascular events and cognitive dysfunction compared to a conservative target (< 140 mm Hg) in adults with hypertension?
Answers are grounded in this paper and cite their sources.
This correspondence calls for an urgent update to the 2022 AAFP Hypertension Guideline to recommend an SBP target of < 130 mm Hg for high-risk patients, aligning with modern international guidelines and recent large clinical trial evidence demonstrating reductions in cardiovascular events, mortality, and cognitive decline.
Over the past decade, multiple randomized controlled trials have shown lower systolic blood pressure (SBP) targets reduce cardiovascular events and cognitive dysfunction. Despite this, current family medicine guidance continues to endorse a conservative target of < 140 mm Hg regardless of patient
No takes yet. Share an insight, caveat, or question.
Brian McDaniel (2026) conducted a letter in Hypertension. Intensive systolic blood pressure target (<130 or <120 mm Hg) vs. Conservative systolic blood pressure target (<140 mm Hg) was evaluated on Composite major cardiovascular events (HR 0.76, 95% CI 0.72-0.81). Lower systolic blood pressure targets (<130 mm Hg) reduced composite major cardiovascular events by 24% and all-cause mortality by 13% in cited meta-analyses.
Synapse has enriched 10 related papers. Consider them for comparative context: